Screener
Journey Medical Corporation DERM Q1 2026 earnings
Reported May 13, 2026 · After market close
Revenue$16.0MBeat by $488.3K
EPS-$0.08Miss by $0.01
Revenue estimate$15.5M
EPS estimate-$0.07
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$21.9M
EPS estimate$0.02
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Journey Medical Corporation report Q1 2026 earnings?
- Journey Medical Corporation (DERM) reported Q1 2026 earnings on May 13, 2026 after market close.
- What were Journey Medical Corporation's Q1 2026 revenue and EPS?
- Journey Medical Corporation reported revenue of $16.0M and eps of $-0.08 for Q1 2026.
- Did Journey Medical Corporation beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $15.5M by $488.3K. EPS missed the consensus estimate of $-0.07 by $0.01.
- How did Journey Medical Corporation's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 21.5% from $13.1M a year earlier and eps grew 55.6% from $-0.18.
- Where can I find Journey Medical Corporation's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-060232) and the 10-Q periodic report (0001104659-26-060297) directly on SEC EDGAR. The filing index links above go to sec.gov.
